Daniel J. Coughlin

Person

Robbinsville, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment methods using metal-binding targeted polypeptide constructs
- Patent number 5,609,847
- Issue date Mar 11, 1997
- Cytogen Corporation
- Benjamin A. Belinka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metal-binding targeted polypeptide constructs
- Patent number 5,593,656
- Issue date Jan 14, 1997
- Cytogen Corporation
- Benjamin A. Belinka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted thioureas as bifunctional chelators
- Patent number 5,585,468
- Issue date Dec 17, 1996
- Cytogen Corporation
- Daniel J. Coughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metal-binding targeted polypeptide constructs
- Patent number 5,578,288
- Issue date Nov 26, 1996
- Cytogen Corporation
- Benjamin A. Belinka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bifunctional isothiocyanate derived thiocarbonyls as ligands for me...
- Patent number 5,527,885
- Issue date Jun 18, 1996
- Cytogen Corporation
- Daniel J. Coughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-alkaline purification of aminophosphonic acids
- Patent number 5,495,042
- Issue date Feb 27, 1996
- Cytogen Corporation
- Benjamin A. Belinka
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metal-binding targeted polypeptide constructs
- Patent number 5,449,761
- Issue date Sep 12, 1995
- Cytogen Corporation
- Benjamin A. Belinka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bifunctional isothiocyanate derived thiocarbonyls as ligands for me...
- Patent number 5,326,856
- Issue date Jul 5, 1994
- Cytogen Corporation
- Daniel J. Coughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the preparation of GYK-DTPA
- Patent number H1312
- Issue date May 3, 1994
- Cytogen Corporation
- Daniel J. Coughlin
- 530 - Chemistry: natural resins or derivatives
Information Patent Grant
Amine derivatives of anthracycline antibodies
- Patent number 5,162,512
- Issue date Nov 10, 1992
- Cytogen Corporation
- H. Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amine-containing porphyrin derivatives
- Patent number 5,156,840
- Issue date Oct 20, 1992
- Cytogen Corporation
- John W. F. Goers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amine derivatives of folic acid analogs
- Patent number 5,140,104
- Issue date Aug 18, 1992
- Cytogen Corporation
- Daniel J. Coughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiohalogenated compounds for site specific labeling
- Patent number 4,966,999
- Issue date Oct 30, 1990
- Cytogen Corporation
- Daniel J. Coughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amine derivatives of anthracycline antibiotics
- Patent number 4,950,738
- Issue date Aug 21, 1990
- Cytogen Corporation
- H. Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-therapeutic agent conjugates
- Patent number 4,867,973
- Issue date Sep 19, 1989
- Cytogen Corporation
- John W. F. Goers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Daniel J. Coughlin

Person

Patents Grantslast 30 patents

Treatment methods using metal-binding targeted polypeptide constructs

Metal-binding targeted polypeptide constructs

Substituted thioureas as bifunctional chelators

Metal-binding targeted polypeptide constructs

Bifunctional isothiocyanate derived thiocarbonyls as ligands for me...

Non-alkaline purification of aminophosphonic acids

Metal-binding targeted polypeptide constructs

Bifunctional isothiocyanate derived thiocarbonyls as ligands for me...

Method for the preparation of GYK-DTPA

Amine derivatives of anthracycline antibodies

Amine-containing porphyrin derivatives

Amine derivatives of folic acid analogs

Radiohalogenated compounds for site specific labeling

Amine derivatives of anthracycline antibiotics

Antibody-therapeutic agent conjugates